|
Resolution: standard / high Figure 2.
Comparison of biomarkers significantly different between ACR responders and nonresponders
for golimumab-treated patients. Mean ± SD comparison of biomarkers (log2 transformed) that were significantly different between ACR 20 and ACR 50 responders
and nonresponders for golimumab-treated patients in the Training and Test Subsets.
Visvanathan et al. Arthritis Research & Therapy 2010 12:R211 doi:10.1186/ar3188 |
